Trials / Completed
CompletedNCT05012735
A Study of a Hydrocolloid Bandage on Pimples
An Evaluation of the Safety and Efficacy of a Hydrocolloid Bandage on Pimples
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Johnson & Johnson Consumer Inc. (J&JCI) · Industry
- Sex
- All
- Age
- 12 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the effectiveness and tolerability of a hydrocolloid bandage on pimples when used overnight for one week.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Study Cleanser (Neutrogena Ultra Gentle Daily Cleanser with Pro Vitamin B5) | Participants will wash their face with the study cleanser (Neutrogena Ultra Gentle Daily Cleanser with Pro Vitamin B5) for up to 14 days. |
| DEVICE | Prototype Ultrathin Hydrocolloid Bandage | Participants will cover their closed and popped pimples in the evening with one or two bandages from Days 0 through 6. |
Timeline
- Start date
- 2021-07-19
- Primary completion
- 2021-09-13
- Completion
- 2021-09-13
- First posted
- 2021-08-19
- Last updated
- 2022-09-16
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05012735. Inclusion in this directory is not an endorsement.